Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Poziotinib as a clinically active inhibitor of EGFR and HER2 exon 20 mutations. Have a read: https://www.m3india.in/contents/clinical_news/poziotinib-as-a-clinically-active-inhibitor-of?utm_campaign=unset&utm_medium=share&utm_source=ref_wa